These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23871773)

  • 21. A study of the environmental determinants of malaria and schistosomiasis in the Philippines using Remote Sensing and Geographic Information Systems.
    Leonardo LR; Rivera PT; Crisostomo BA; Sarol JN; Bantayan NC; Tiu WU; Bergquist NR
    Parassitologia; 2005 Mar; 47(1):105-14. PubMed ID: 16044679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Malaria kills over 1 million people every year. Genomic mapping of malaria parasite and mosquito raise hope for a vaccine as well as more effective drugs].
    Kahl U
    Lakartidningen; 2003 Mar; 100(12):1042-7. PubMed ID: 12693137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis.
    Hotez PJ; Bethony JM; Oliveira SC; Brindley PJ; Loukas A
    Expert Rev Vaccines; 2008 Aug; 7(6):745-52. PubMed ID: 18665774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Malaria research for developing countries: the PAL+ program].
    Agid F
    Med Trop (Mars); 2003; 63(3):236-40. PubMed ID: 14579458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological aspects of some parasitic infections.
    Ruitenberg EJ; Buys J
    Tijdschr Diergeneeskd; 1980 Jul; 105(14):suppl 3:166-75. PubMed ID: 6999658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection and identification of malaria vaccine target molecule using bioinformatics and DNA vaccination.
    Shuaibu MN; Kikuchi M; Cherif MS; Helegbe GK; Yanagi T; Hirayama K
    Vaccine; 2010 Oct; 28(42):6868-75. PubMed ID: 20709002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The PAL+ program, an incentive concerted action about malaria and associated infectious diseases, for developing countries].
    Agid F
    J Soc Biol; 2004; 198(3):207-11. PubMed ID: 15662937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress with new malaria vaccines.
    Webster D; Hill AV
    Bull World Health Organ; 2003; 81(12):902-9. PubMed ID: 14997243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of novel malaria DNA vaccine candidates using full-length cDNA library.
    Shibui A; Nakae S; Watanabe J; Sato Y; Tolba ME; Doi J; Shiibashi T; Nogami S; Sugano S; Hozumi N
    Exp Parasitol; 2013 Nov; 135(3):546-50. PubMed ID: 24055215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meetings on Plasmodium vivax and Schistosoma japonicum in Asia.
    TDR News; 1999 Oct; (60):4. PubMed ID: 12295473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress on vaccines against parasites.
    Engers HD; Bergquist R; Modabber F
    Dev Biol Stand; 1996; 87():73-84. PubMed ID: 8854004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Next-Generation Technologies and Systems Biology for the Design of Novel Vaccines Against Apicomplexan Parasites.
    Tomazic ML; Marugan-Hernandez V; Rodriguez AE
    Front Vet Sci; 2021; 8():800361. PubMed ID: 35071390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Segmenting the etiological agent of schistosomiasis for high-content screening.
    Asarnow DE; Singh R
    IEEE Trans Med Imaging; 2013 Jun; 32(6):1007-18. PubMed ID: 23428618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schistosomiasis: challenges for control, treatment and drug resistance.
    Fenwick A; Webster JP
    Curr Opin Infect Dis; 2006 Dec; 19(6):577-82. PubMed ID: 17075334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections.
    You H; Jones MK; Gordon CA; Arganda AE; Cai P; Al-Wassiti H; Pouton CW; McManus DP
    Clin Microbiol Rev; 2023 Mar; 36(1):e0024121. PubMed ID: 36625671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics meets parasitology.
    Cantacessi C; Campbell BE; Jex AR; Young ND; Hall RS; Ranganathan S; Gasser RB
    Parasite Immunol; 2012 May; 34(5):265-75. PubMed ID: 21615422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing antibacterial vaccines in genomics and proteomics era.
    Kaushik DK; Sehgal D
    Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress in the molecular biology of malaria and the immunology of nematode infections.
    Arizono N; Nakanihsi K; Horii T; Tanabe K
    Trends Parasitol; 2007 Apr; 23(4):175-81. PubMed ID: 17320481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel omics technologies in nutrition research.
    Zhang X; Yap Y; Wei D; Chen G; Chen F
    Biotechnol Adv; 2008; 26(2):169-76. PubMed ID: 18164161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.